COMMUNIQUÉS West-GlobeNewswire

Idera Pharmaceuticals Announces Appointment of Howard Pien to its Board of Directors

18/09/2018 - 22:01

EXTON, Pa., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a pharmaceutical company focused on the development and commercialization of its proprietary immune modulator, tilsotolimod, for [...]

Principia Biopharma Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

18/09/2018 - 22:00

SOUTH SAN FRANCISCO, Calif., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Principia or the Company) (Nasdaq: PRNB), a clinical-stage biopharmaceutical company dedicated to bringing transformative oral [...]

Good Samaritan Canada acquires Delta View Campus of Care

18/09/2018 - 20:52

DELTA, B.C., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Good Samaritan Canada (GSC) and Devji Holdings Ltd. have reached an agreement that has transferred ownership of Delta View Campus of Care to Good Samaritan Canada [...]

Running Marathons and Co-Founding a Company: Accomplished Octogenarian Scientist Provides Inspiration for Senior Runners

18/09/2018 - 20:51

CHICAGO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Inspirotec Inc., a Chicago-based startup company with proprietary technology for measuring airborne allergens, today announced that its co-founder and Chief Scientific Officer [...]

Mount Sinai Joins Test Validation Trial of bioAffinity’s CyPath® Lung

18/09/2018 - 20:00

SAN ANTONIO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced that the Icahn School of Medicine at Mount Sinai (ISMMS) in New York, NY, will be a clinical [...]

Bavarian Nordic Announces Initiation of Phase 2 Trial Evaluating the Combination Therapy of CV301 and Atezolizumab in Bladder Cancer

18/09/2018 - 19:51

Bavarian Nordic-sponsored study has commenced dosing Study marks the second of three planned Phase 2 combination studies of CV301 with checkpoint inhibitors in solid tumors COPENHAGEN, Denmark, September 18, 2018 - [...]

Capital Increase in Genmab as a Result of Employee Warrant Exercise

18/09/2018 - 18:16

Company Announcement Copenhagen, Denmark; September 18, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 18,414 shares as a consequence of the exercise of employee warrants. The increase is [...]

UPDATE: Gala Pharmaceutical to Form Strategic Alliances to Boost Demand for Cannabis Testing Facilities

18/09/2018 - 17:53

IRVINE, Calif., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Gala Pharmaceutical, Inc. (Ticker: GLPH), an emerging cannabis testing company, today announced it expects to form strategic alliances with GreenGro Technologies ( [...]

SPINEWAY : Compte-rendu de l'Assemblée Générale du 13 septembre 2018

18/09/2018 - 17:46

Communiqué de presse Ecully, le 18 septembre 2018 Compte-rendu de l'Assemblée Générale L'Assemblée Générale Mixte des actionnaires de Spineway, spécialiste des implants et ancillaires chirurgicaux pour le traitement des [...]

Marrone Bio Innovations Announces Distribution Partnership with Hop Tri Investment Corporation in Vietnam

18/09/2018 - 17:30

Regalia ® , Grandevo ® and Majestene ® to Offer Vietnamese Growers Effective Biological Solutions as Regional Chemical Pesticide Reduction Begins DAVIS, Calif., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations [...]

Radient Technologies Inc. Unaware of Any Material Change

18/09/2018 - 17:28

EDMONTON, Alberta, Sept. 18, 2018 (GLOBE NEWSWIRE) -- At the request of IIROC, Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI ) wishes to confirm that the Company’s management is unaware of [...]

Elite Pharmaceuticals Files ANDA for Codeine and Acetaminophen Combo

18/09/2018 - 17:13

NORTHVALE, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, [...]

Valeria Robinson-Baker, B.S.Pharm., R.Ph., C.Ph., is Appointed to the American Health Council’s Industry Board

18/09/2018 - 16:59

NEW YORK, Sept. 18, 2018 (GLOBE NEWSWIRE) -- The American Health Council appoints Valeria Robinson-Baker, B.S.Pharm., R.Ph., C.Ph., to its Industry Board. A supervisor of the Non-Sterile Compounding and Hazardous Drugs [...]

Foamix Announces Closing of its Follow-on Offering of Ordinary Shares and Full Exercise of its Option by the Underwriters

18/09/2018 - 16:55

REHOVOT, Israel, and BRIDGEWATER, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (“Foamix”) (Nasdaq: FOMX), a clinical-stage specialty pharmaceutical company focused on developing and [...]

Medtronic Announces Clinical Study of Transcatheter Aortic Valve Replacement in Aortic Stenosis Patients with Bicuspid Valves

18/09/2018 - 16:03

Medtronic Receives FDA Approval for Revised TAVR Labeling and Begins Investigational Study of Low Risk Patients with Bicuspid Valves DUBLIN - September 18, 2018 - Medtronic plc (NYSE:MDT) today announced that the U.S. [...]

Emblem and Canntab to Commence Clinical Testing of 12-Hour Extended Release Cannabis Tablets

18/09/2018 - 15:18

TORONTO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis [...]

NewLink Genetics to Participate in the Cantor Global Healthcare Conference

18/09/2018 - 15:00

AMES, Iowa, Sept. 18, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) announced today that the Company will present at the 2018 Cantor Global Healthcare Conference on Wednesday, October 3, 2018, at 4 [...]

PHM Announces Accretive Acquisition of Respiratory Services Focused Business

18/09/2018 - 15:00

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Protech Home [...]

Phoenix Life Sciences International Completes Merger and Announces Global Production Strategy

18/09/2018 - 15:00

DENVER, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (“Phoenix Life”), an adaptive healthcare solutions company, today announced its common stock is now publicly traded in the United [...]